Mumbai, Feb 12 (UNI) Roche Diagnostics and Mankind Pharma, one of India's fastest growing pharmaceutical companies, today announced an exclusive marketing agreement wherein Mankind Pharma will undertake marketing activities for ''Accu-Chek Go'', a newly launched blood glucose monitoring device by Roche Diagnostics, in India.
''Accu-Chek Go'' is a new, fast, low blood volume system that offers advanced and accurate testing with its hygienic test strip ejection and customizable safety settings.
''With Mankind's strong distribution and marketing force, 'Accu-Chek Go' will be available across 500 cities in India. The purpose of this co-operation is to raise awareness for diabetes and to spread the message of self-monitoring in Indian homes.
Both parties have the declared goal to enable people with diabetes leading a life as normal as possible despite their condition and to provide efficient and effective diabetes management solutions to them in metros, mini metros and rural towns in India,'' said Regional Head of Asia Pacific Diabetes Care Sanjeev Johar while speaking to reporters.
''Globally we have been at the forefront of creating pioneering products and solutions in blood glucose monitoring.
Diabetes has reached epidemic proportions in India and accessibility of services for improved diabetes management has always been a challenge. This arrangement provides India's vast urban and suburban areas access to our best-in-class products and services, and aligns perfectly with our philosophy of meeting 'unmet needs' in our chosen markets,'' he added.
He further said, focus of the co-operation is to leverage the importance of proper diabetes management and at the same time to increase the availability of efficient tools for people with diabetes and their caregivers. With the agreement on ''Accu-Chek Go'' both partners seek to fulfill the increasing demand of information, adequate education and supply to all parties involved in diabetes management.
UNI LS DB SM1746